We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 387

Third time is the charm for WildTangent challenge of patent eligibility of Ultramercial patent

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • November 17 2014

In its third opinion reviewing the same district court decision, the Federal Circuit this time affirmed the district court's grant of WildTangent's

Federal Circuit’s post-Alice eligibility analysis of business methods

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • November 16 2014

The Federal Circuit in Ultramercial, Inc. v. WildTangent, Inc., held that an "entrepreneurial" multi-step process for distributing copyrighted media

Federal Circuit looks for inventive concept in Sequenom patent

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • November 10 2014

On November 7, 2014, the Federal Circuit heard oral arguments in Aria Diagnostics, Inc. v. Sequenom, Inc., where Sequenom is appealing the district

District court finds Genetic Technologies patent invalid under 101 on motion to dismiss

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • November 6 2014

Judge Stark of the U.S. District Court for the District of Delaware granted defendants' motion to dismiss Genetic Technologies, Ltd.'s patent

Is the Commil defense underutilized in patent cases?

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • November 5 2014

It has now been more than a year since the Federal Circuit rendered its decision in the Commil case providing a defense to the intent prong for active

Supreme Court asked to review standing in stem cell challenge

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • November 2 2014

The Public Patent Foundation and Consumer Watchdog (collectively “CW”) petitioned the U.S. Supreme Court on October 31, 2014, seeking reversal of the

Federal Circuit judges disagree on use of post filing date evidence of nonobviousness

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • October 21 2014

On October 20, 2014, the Federal Circuit issued an order denying the petition for rehearing or rehearing en banc filed in Bristol-Meyers Squibb Co. v

Myriad’s continuing patent debate

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • October 20 2014

On October 6, 2014, the U.S. Court of Appeals for the Federal Circuit entertained oral argument in the interlocutory appeal of the district court's

PTAB requires additional showing for cross-examination if testimony was prepared for another proceeding

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • October 16 2014

A recent order from the Patent Trial and Appeal Board ("Board") in an inter partes review illustrates how the Board may handle situations where a

Federal Circuit jurisdiction over patent contract disputes

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • October 9 2014

In a precedential order issued in Jang v. Boston Scientific Corp., the Federal Circuit held that it has jurisdiction over the parties' patent-related